Activated Type II Collagen Reactive T Cells are not Eliminated by in vivo Anti-CD4 Treatment. Implications for Therapeutic Approaches on Autoimmune Arthritis
- 30 April 1992
- journal article
- Published by Elsevier in Immunobiology
- Vol. 184 (4-5) , 359-371
- https://doi.org/10.1016/s0171-2985(11)80593-0
Abstract
No abstract availableKeywords
Funding Information
- Stiftelsen Konung Gustaf V:s 80-årsfond
- Crafoordska Stiftelsen
- Medicinska Forskningsrådet
This publication has 18 references indexed in Scilit:
- Treatment of rheumatoid arthritis with an anti‐CD4 monoclonal antibodyArthritis & Rheumatism, 1991
- Analysis of type II collagen‐reactive T cells in the mouse I. Different regulation of autoreactive vs. non‐autoreactive anti‐type II collagen T cells in the DBA/1 mouseEuropean Journal of Immunology, 1990
- Manipulation of T-Cell Responses with Monoclonal AntibodiesAnnual Review of Immunology, 1989
- The progression of the inflammation in established collagen‐induced arthritis can be altered by treatments with immunological or pharmacological agents which inhibit T cell activitiesEuropean Journal of Immunology, 1988
- In vivo immunomodulation by monoclonal anti-L3T4Cellular Immunology, 1987
- Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4.The Journal of Experimental Medicine, 1985
- Monoclonal Antibodies Against Rat Immunoglobulin Kappa ChainsHybridoma, 1982
- Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates.The Journal of Experimental Medicine, 1981
- Immunisation against heterologous type II collagen induces arthritis in miceNature, 1980
- Autoimmunity to type II collagen an experimental model of arthritis.The Journal of Experimental Medicine, 1977